Literature DB >> 32750111

Impaired retinal microvascular function predicts long-term adverse events in patients with cardiovascular disease.

James D Theuerle1,2, Ali H Al-Fiadh1,2, Fakir M Amirul Islam3, Sheila K Patel2, Louise M Burrell1,2, Tien Yin Wong4, Omar Farouque1,2.   

Abstract

AIMS: Endothelial dysfunction is a precursor to the development of symptomatic atherosclerosis. Retinal microvascular reactivity to flicker light stimulation is a marker of endothelial function and can be quantified in vivo. We sought to determine whether retinal microvascular endothelial dysfunction predicts long-term major adverse cardiovascular events (MACE). METHODS AND
RESULTS: In a single-centre prospective observational study, patients with coronary artery disease (CAD) or cardiovascular risk factors underwent dynamic retinal vessel assessment in response to flicker light stimulation and were followed up for MACE. Retinal microvascular endothelial dysfunction was quantified by measuring maximum flicker light-induced retinal arteriolar dilatation (FI-RAD) and flicker light-induced retinal venular dilatation (FI-RVD). In total, 252 patients underwent dynamic retinal vessel assessment and 242 (96%) had long-term follow-up. Of the 242 patients, 88 (36%) developed MACE over a median period of 8.6 years (interquartile range 6.0-9.1). After adjustment for traditional risk factors, patients within the lowest quintile of FI-RAD had the highest risk of MACE [odds ratio (OR) 5.21; 95% confidence interval (CI) 1.78-15.28]. Patients with lower FI-RAD were also more likely to die (OR 2.09; 95% CI 1.00-4.40, per standard deviation decrease in FI-RAD). In Kaplan-Meier analysis, patients with FI-RAD responses below the cohort median of 1.4% exhibited reduced MACE-free survival (55.5 vs. 71.5%; log-rank P = 0.004). FI-RVD was not predictive of MACE.
CONCLUSION: Retinal arteriolar endothelial dysfunction is an independent predictor of MACE in patients with CAD or cardiovascular risk factors. Dynamic retinal vessel analysis may provide added benefit to traditional risk factors in stratifying patients at risk for cardiovascular events. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Dynamic vessel analysis; Endothelial function; Microvascular dysfunction; Retinal circulation

Mesh:

Year:  2021        PMID: 32750111     DOI: 10.1093/cvr/cvaa245

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Risk Assessment of CHD Using Retinal Images with Machine Learning Approaches for People with Cardiometabolic Disorders.

Authors:  Yimin Qu; Jack Jock-Wai Lee; Yuanyuan Zhuo; Shukai Liu; Rebecca L Thomas; David R Owens; Benny Chung-Ying Zee
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

2.  Hypertension and retinal microvascular dysfunction (HyperVasc): protocol of a randomised controlled exercise trial in patients with hypertension.

Authors:  Lukas Streese; Joséphine Gander; Justin Carrard; Christoph Hauser; Timo Hinrichs; Arno Schmidt-Trucksäss; Konstantin Gugleta; Henner Hanssen
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

3.  A stronger association of diabetes mellitus with impaired hyperaemia using a novel ECG-gated device compared with peripheral arterial tonometry.

Authors:  Anchal Lal; Neha Dave; Michael Anthony Barry; Annika Sood; Paul Mitchell; Aravinda Thiagalingam
Journal:  Int Ophthalmol       Date:  2022-06-07       Impact factor: 2.029

4.  Assessment of the impact of HIV infection and anti-retroviral treatment on the cardiometabolic health of pregnant mothers and their offspring (ARTMOMSBABES).

Authors:  Benedicta Ngwenchi Nkeh-Chungag; Godwill Azeh Engwa; Charles Businge; Mziwohlanga Mdondolo; Magdevy Pajaro Medina; Nandu Goswami
Journal:  BMC Cardiovasc Disord       Date:  2021-06-30       Impact factor: 2.298

5.  Normative data and standard operating procedures for static and dynamic retinal vessel analysis as biomarker for cardiovascular risk.

Authors:  Lukas Streese; Giulia Lona; Jonathan Wagner; Raphael Knaier; Andri Burri; Gilles Nève; Denis Infanger; Walthard Vilser; Arno Schmidt-Trucksäss; Henner Hanssen
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

Review 6.  The "Hitchhiker's Guide to the Galaxy" of Endothelial Dysfunction Markers in Human Fertility.

Authors:  Daniele Santi; Giorgia Spaggiari; Carla Greco; Clara Lazzaretti; Elia Paradiso; Livio Casarini; Francesco Potì; Giulia Brigante; Manuela Simoni
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.